Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP249394.RA-XEUBk5WtIzOHQhlrykLTnpuTkkaeDO75uuT3WF04gM130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249394.RA-XEUBk5WtIzOHQhlrykLTnpuTkkaeDO75uuT3WF04gM130_provenance.
• NP471508.RAq7-2sF9A5z18NGSSBNzvzy999JAcDeQWSDPqnqB6XVg130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471508.RAq7-2sF9A5z18NGSSBNzvzy999JAcDeQWSDPqnqB6XVg130_provenance.
• NP358133.RAVSJ27K3PESDwnCmkJXrnzTST2dy9K-qZAbHrnx6tx7U130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358133.RAVSJ27K3PESDwnCmkJXrnzTST2dy9K-qZAbHrnx6tx7U130_provenance.
• NP905356.RARWnEGy60mbqjThSq9RU8PG3kEAh8vwU0zUvKsof-WuM130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905356.RARWnEGy60mbqjThSq9RU8PG3kEAh8vwU0zUvKsof-WuM130_provenance.
• NP433783.RAJkavcnUfNdxyiab9xBpCQXQ2K49lSML5Lday6iGHC9U130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433783.RAJkavcnUfNdxyiab9xBpCQXQ2K49lSML5Lday6iGHC9U130_provenance.
• NP278539.RAMqX-DPHbS9Y1TNa4C4D4jqVBk2f4htg0iI3-1HGSkwo130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278539.RAMqX-DPHbS9Y1TNa4C4D4jqVBk2f4htg0iI3-1HGSkwo130_provenance.
• assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP558718.RApM_mUJGOtfagxQCH73LcY-rBAsBF-YWHzJOgAmpFgds130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558718.RApM_mUJGOtfagxQCH73LcY-rBAsBF-YWHzJOgAmpFgds130_provenance.
• NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.